Related Experiment Videos
Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
1Mycology Department, Instituto Nacional de Enfermedades Infecciosas, ANLIS: Dr. Carlos G. Malbrán, Buenos Aires, Argentina. lrodero@mail.retina.ar
Medical Mycology
|July 13, 2000
Summary
Antifungal susceptibility testing for Cryptococcus neoformans is crucial for treating cryptococcal meningitis in AIDS patients. Timed-kill curves for amphotericin B showed promise in predicting treatment outcomes.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Cryptococcus neoformans infections, particularly cryptococcal meningitis, pose a significant challenge in immunocompromised individuals, especially those with acquired immune deficiency syndrome (AIDS).
- Current therapies like amphotericin B and fluconazole have limitations, leading to suboptimal outcomes, recurrence, and treatment failures.
- Reliable antifungal susceptibility testing methods for C. neoformans are lacking, hindering personalized treatment strategies.
Purpose of the Study:
- To evaluate the utility of in vitro antifungal susceptibility testing methods, including minimal inhibitory concentration (MIC), minimal fungicidal concentration (MFC), and timed-kill curves, for predicting clinical outcomes in AIDS patients with cryptococcal meningitis.
- To assess the correlation between MIC and MFC of amphotericin B and fluconazole with clinical outcomes.
Main Methods:
- A retrospective study was conducted on 16 clinical isolates of C. neoformans from AIDS patients diagnosed with cryptococcal meningitis.
- Minimal inhibitory concentrations (MICs) for amphotericin B and fluconazole were determined.
- Minimal fungicidal concentrations (MFCs) and timed-kill curves for amphotericin B were evaluated against the isolates.
Main Results:
- No significant correlation was observed between the minimal inhibitory concentration (MIC) of amphotericin B and clinical outcomes.
- In certain cases, the minimal fungicidal concentration (MFC) appeared to be a better predictor of patient outcome than MIC.
- Amphotericin B timed-kill curves demonstrated a potential correlation with the clinical outcomes of patients with AIDS-associated cryptococcal meningitis.
Conclusions:
- In vitro antifungal susceptibility testing, particularly amphotericin B timed-kill curves, may offer valuable insights into predicting treatment success for cryptococcal meningitis in AIDS patients.
- Further prospective studies are essential to validate these findings and establish the clinical utility of these in vitro methods for guiding antifungal therapy.